Hikma Pharmaceuticals PLC (H5P.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:49PM CEST
| Previous close | 22.60 |
| Open | 22.60 |
| Bid | 23.00 x N/A |
| Ask | 23.40 x N/A |
| Day's range | 22.60 - 23.00 |
| 52-week range | 19.70 - 25.60 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 5.103B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 28.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.66 (2.94%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- Simply Wall St.
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
- Fool.co.uk
I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
- Fool.co.uk
2 FTSE 100 shares investors should consider buying for a winning portfolio
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.
© 2024 Yahoo. All rights reserved.